ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering
Published in Healthcare Finance, Tax and Law Weekly, April 18th, 2007
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced the pricing of its public offering of 5,750,000 shares of its common stock. The public offering price of $15.50 per share will result in gross proceeds of $89.1 million and net proceeds, after underwriting commissions and other offering expenses, of $83.5 million to ACADIA. ACADIA also granted the underwriters a 30-day option to purchase up to 862,500 additional shares of its common stock, which could raise the net proceeds to ACADIA to $96.1 million, if exercised in full. All of the shares are being sold by ACADIA.
The book-running managers for the offering are Banc of America Securities LLC and Lehman Brothers Inc.,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Proposed Public Stock Offering - Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences to Present at BioFinance Canada 2007 and Announces Filing of Annual Report on Form 10-K - Advitech
Advitech Announces the Closing of an $885,000 Private Placement and a New Stock Option Grant - Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals Files Shelf Registration Statement - Anesthesia
Research and Markets: Medical Device Company Intelligence Report Provides a Full Review of the Smiths Medical Medical Device Activities and Finances - AngioDynamics, Inc.
AngioDynamics Announces Plan to Launch NeverTouch VenaCure Product Line - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
